カテゴリ： 世界, 医療/バイオ, Market Monitor Global

CD3標的薬物のグローバル市場展望 2023年-2029年：CD20+CD3ターゲット、CD3ターゲット、BCMA+CD3ターゲット、CD3+gp100ターゲット、CD3+GPRC5Dターゲット

■ 英語タイトル：CD3 Target Drug Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14268）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14268
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[CD3標的薬物のグローバル市場展望 2023年-2029年：CD20+CD3ターゲット、CD3ターゲット、BCMA+CD3ターゲット、CD3+gp100ターゲット、CD3+GPRC5Dターゲット]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のCD3標的薬物市場規模と予測を収録しています。・世界のCD3標的薬物市場：売上、2018年-2023年、2024年-2029年
・世界のCD3標的薬物市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のCD3標的薬物市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CD20+CD3ターゲット」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

CD3標的薬物のグローバル主要企業は、Pfizer Inc.、 Johnson & Johnson、 AbbVie, Inc.、 Genmab A/S、 Roche、 Sanofi、 Immunocore Ltd.、 Regeneron Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、CD3標的薬物のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のCD3標的薬物市場：タイプ別、2018年-2023年、2024年-2029年
世界のCD3標的薬物市場：タイプ別市場シェア、2022年
・CD20+CD3ターゲット、CD3ターゲット、BCMA+CD3ターゲット、CD3+gp100ターゲット、CD3+GPRC5Dターゲット

世界のCD3標的薬物市場：用途別、2018年-2023年、2024年-2029年
世界のCD3標的薬物市場：用途別市場シェア、2022年
・骨髄腫、リンパ腫、臓器移植拒絶反応、その他

世界のCD3標的薬物市場：地域・国別、2018年-2023年、2024年-2029年
世界のCD3標的薬物市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるCD3標的薬物のグローバル売上、2018年-2023年
・主要企業におけるCD3標的薬物のグローバル売上シェア、2022年
・主要企業におけるCD3標的薬物のグローバル販売量、2018年-2023年
・主要企業におけるCD3標的薬物のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer Inc.、 Johnson & Johnson、 AbbVie, Inc.、 Genmab A/S、 Roche、 Sanofi、 Immunocore Ltd.、 Regeneron Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
CD3標的薬物市場の定義
市場セグメント
世界のCD3標的薬物市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のCD3標的薬物市場規模
世界のCD3標的薬物市場規模：2022年 VS 2029年
世界のCD3標的薬物市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのCD3標的薬物の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のCD3標的薬物製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：CD20+CD3ターゲット、CD3ターゲット、BCMA+CD3ターゲット、CD3+gp100ターゲット、CD3+GPRC5Dターゲット
CD3標的薬物のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：骨髄腫、リンパ腫、臓器移植拒絶反応、その他
CD3標的薬物の用途別グローバル売上・予測

・地域別市場分析
地域別CD3標的薬物市場規模 2022年と2029年
地域別CD3標的薬物売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer Inc.、 Johnson & Johnson、 AbbVie, Inc.、 Genmab A/S、 Roche、 Sanofi、 Immunocore Ltd.、 Regeneron Pharmaceuticals
...

This research report provides a comprehensive analysis of the CD3 Target Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global CD3 Target Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of CD3 Target Drug, challenges faced by the industry, and potential opportunities for market players.
The global CD3 Target Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The CD3 Target Drug market presents opportunities for various stakeholders, including Myeloma, Lymphoma. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in CD3 Target Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global CD3 Target Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the CD3 Target Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the CD3 Target Drug market.
Market Overview: The report provides a comprehensive overview of the CD3 Target Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., CD20+CD3 Target, CD3 Target), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the CD3 Target Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the CD3 Target Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the CD3 Target Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the CD3 Target Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the CD3 Target Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the CD3 Target Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for CD3 Target Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the CD3 Target Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
CD3 Target Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
CD20+CD3 Target
CD3 Target
BCMA+CD3 Target
CD3+gp100 Target
CD3+GPRC5D Target
Market segment by Application
Myeloma
Lymphoma
Organ Transplant Rejection
Other
Global CD3 Target Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer Inc.
Johnson & Johnson
AbbVie, Inc.
Genmab A/S
Roche
Sanofi
Immunocore Ltd.
Regeneron Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of CD3 Target Drug, market overview.
Chapter 2: Global CD3 Target Drug market size in revenue and volume.
Chapter 3: Detailed analysis of CD3 Target Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CD3 Target Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global CD3 Target Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 CD3 Target Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CD3 Target Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CD3 Target Drug Overall Market Size
2.1 Global CD3 Target Drug Market Size: 2022 VS 2029
2.2 Global CD3 Target Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global CD3 Target Drug Sales: 2018-2029
3 Company Landscape
3.1 Top CD3 Target Drug Players in Global Market
3.2 Top Global CD3 Target Drug Companies Ranked by Revenue
3.3 Global CD3 Target Drug Revenue by Companies
3.4 Global CD3 Target Drug Sales by Companies
3.5 Global CD3 Target Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 CD3 Target Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers CD3 Target Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 CD3 Target Drug Players in Global Market
3.8.1 List of Global Tier 1 CD3 Target Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 CD3 Target Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global CD3 Target Drug Market Size Markets, 2022 & 2029
4.1.2 CD20+CD3 Target
4.1.3 CD3 Target
4.1.4 BCMA+CD3 Target
4.1.5 CD3+gp100 Target
4.1.6 CD3+GPRC5D Target
4.2 By Type – Global CD3 Target Drug Revenue & Forecasts
4.2.1 By Type – Global CD3 Target Drug Revenue, 2018-2023
4.2.2 By Type – Global CD3 Target Drug Revenue, 2024-2029
4.2.3 By Type – Global CD3 Target Drug Revenue Market Share, 2018-2029
4.3 By Type – Global CD3 Target Drug Sales & Forecasts
4.3.1 By Type – Global CD3 Target Drug Sales, 2018-2023
4.3.2 By Type – Global CD3 Target Drug Sales, 2024-2029
4.3.3 By Type – Global CD3 Target Drug Sales Market Share, 2018-2029
4.4 By Type – Global CD3 Target Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global CD3 Target Drug Market Size, 2022 & 2029
5.1.2 Myeloma
5.1.3 Lymphoma
5.1.4 Organ Transplant Rejection
5.1.5 Other
5.2 By Application – Global CD3 Target Drug Revenue & Forecasts
5.2.1 By Application – Global CD3 Target Drug Revenue, 2018-2023
5.2.2 By Application – Global CD3 Target Drug Revenue, 2024-2029
5.2.3 By Application – Global CD3 Target Drug Revenue Market Share, 2018-2029
5.3 By Application – Global CD3 Target Drug Sales & Forecasts
5.3.1 By Application – Global CD3 Target Drug Sales, 2018-2023
5.3.2 By Application – Global CD3 Target Drug Sales, 2024-2029
5.3.3 By Application – Global CD3 Target Drug Sales Market Share, 2018-2029
5.4 By Application – Global CD3 Target Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global CD3 Target Drug Market Size, 2022 & 2029
6.2 By Region – Global CD3 Target Drug Revenue & Forecasts
6.2.1 By Region – Global CD3 Target Drug Revenue, 2018-2023
6.2.2 By Region – Global CD3 Target Drug Revenue, 2024-2029
6.2.3 By Region – Global CD3 Target Drug Revenue Market Share, 2018-2029
6.3 By Region – Global CD3 Target Drug Sales & Forecasts
6.3.1 By Region – Global CD3 Target Drug Sales, 2018-2023
6.3.2 By Region – Global CD3 Target Drug Sales, 2024-2029
6.3.3 By Region – Global CD3 Target Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America CD3 Target Drug Revenue, 2018-2029
6.4.2 By Country – North America CD3 Target Drug Sales, 2018-2029
6.4.3 US CD3 Target Drug Market Size, 2018-2029
6.4.4 Canada CD3 Target Drug Market Size, 2018-2029
6.4.5 Mexico CD3 Target Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe CD3 Target Drug Revenue, 2018-2029
6.5.2 By Country – Europe CD3 Target Drug Sales, 2018-2029
6.5.3 Germany CD3 Target Drug Market Size, 2018-2029
6.5.4 France CD3 Target Drug Market Size, 2018-2029
6.5.5 U.K. CD3 Target Drug Market Size, 2018-2029
6.5.6 Italy CD3 Target Drug Market Size, 2018-2029
6.5.7 Russia CD3 Target Drug Market Size, 2018-2029
6.5.8 Nordic Countries CD3 Target Drug Market Size, 2018-2029
6.5.9 Benelux CD3 Target Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia CD3 Target Drug Revenue, 2018-2029
6.6.2 By Region – Asia CD3 Target Drug Sales, 2018-2029
6.6.3 China CD3 Target Drug Market Size, 2018-2029
6.6.4 Japan CD3 Target Drug Market Size, 2018-2029
6.6.5 South Korea CD3 Target Drug Market Size, 2018-2029
6.6.6 Southeast Asia CD3 Target Drug Market Size, 2018-2029
6.6.7 India CD3 Target Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America CD3 Target Drug Revenue, 2018-2029
6.7.2 By Country – South America CD3 Target Drug Sales, 2018-2029
6.7.3 Brazil CD3 Target Drug Market Size, 2018-2029
6.7.4 Argentina CD3 Target Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa CD3 Target Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa CD3 Target Drug Sales, 2018-2029
6.8.3 Turkey CD3 Target Drug Market Size, 2018-2029
6.8.4 Israel CD3 Target Drug Market Size, 2018-2029
6.8.5 Saudi Arabia CD3 Target Drug Market Size, 2018-2029
6.8.6 UAE CD3 Target Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. CD3 Target Drug Major Product Offerings
7.1.4 Pfizer Inc. CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson CD3 Target Drug Major Product Offerings
7.2.4 Johnson & Johnson CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 AbbVie, Inc.
7.3.1 AbbVie, Inc. Company Summary
7.3.2 AbbVie, Inc. Business Overview
7.3.3 AbbVie, Inc. CD3 Target Drug Major Product Offerings
7.3.4 AbbVie, Inc. CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie, Inc. Key News & Latest Developments
7.4 Genmab A/S
7.4.1 Genmab A/S Company Summary
7.4.2 Genmab A/S Business Overview
7.4.3 Genmab A/S CD3 Target Drug Major Product Offerings
7.4.4 Genmab A/S CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.4.5 Genmab A/S Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche CD3 Target Drug Major Product Offerings
7.5.4 Roche CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi CD3 Target Drug Major Product Offerings
7.6.4 Sanofi CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Immunocore Ltd.
7.7.1 Immunocore Ltd. Company Summary
7.7.2 Immunocore Ltd. Business Overview
7.7.3 Immunocore Ltd. CD3 Target Drug Major Product Offerings
7.7.4 Immunocore Ltd. CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.7.5 Immunocore Ltd. Key News & Latest Developments
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Company Summary
7.8.2 Regeneron Pharmaceuticals Business Overview
7.8.3 Regeneron Pharmaceuticals CD3 Target Drug Major Product Offerings
7.8.4 Regeneron Pharmaceuticals CD3 Target Drug Sales and Revenue in Global (2018-2023)
7.8.5 Regeneron Pharmaceuticals Key News & Latest Developments
8 Global CD3 Target Drug Production Capacity, Analysis
8.1 Global CD3 Target Drug Production Capacity, 2018-2029
8.2 CD3 Target Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global CD3 Target Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CD3 Target Drug Supply Chain Analysis
10.1 CD3 Target Drug Industry Value Chain
10.2 CD3 Target Drug Upstream Market
10.3 CD3 Target Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 CD3 Target Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of CD3 Target Drug in Global Market
Table 2. Top CD3 Target Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global CD3 Target Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global CD3 Target Drug Revenue Share by Companies, 2018-2023
Table 5. Global CD3 Target Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global CD3 Target Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers CD3 Target Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers CD3 Target Drug Product Type
Table 9. List of Global Tier 1 CD3 Target Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD3 Target Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global CD3 Target Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global CD3 Target Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global CD3 Target Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global CD3 Target Drug Sales (K Units), 2018-2023
Table 15. By Type - Global CD3 Target Drug Sales (K Units), 2024-2029
Table 16. By Application – Global CD3 Target Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global CD3 Target Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global CD3 Target Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global CD3 Target Drug Sales (K Units), 2018-2023
Table 20. By Application - Global CD3 Target Drug Sales (K Units), 2024-2029
Table 21. By Region – Global CD3 Target Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global CD3 Target Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global CD3 Target Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global CD3 Target Drug Sales (K Units), 2018-2023
Table 25. By Region - Global CD3 Target Drug Sales (K Units), 2024-2029
Table 26. By Country - North America CD3 Target Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America CD3 Target Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America CD3 Target Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America CD3 Target Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe CD3 Target Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe CD3 Target Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe CD3 Target Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe CD3 Target Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia CD3 Target Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia CD3 Target Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia CD3 Target Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia CD3 Target Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America CD3 Target Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America CD3 Target Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America CD3 Target Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America CD3 Target Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa CD3 Target Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa CD3 Target Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa CD3 Target Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa CD3 Target Drug Sales, (K Units), 2024-2029
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. CD3 Target Drug Product Offerings
Table 48. Pfizer Inc. CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson CD3 Target Drug Product Offerings
Table 52. Johnson & Johnson CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. AbbVie, Inc. Company Summary
Table 55. AbbVie, Inc. CD3 Target Drug Product Offerings
Table 56. AbbVie, Inc. CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AbbVie, Inc. Key News & Latest Developments
Table 58. Genmab A/S Company Summary
Table 59. Genmab A/S CD3 Target Drug Product Offerings
Table 60. Genmab A/S CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Genmab A/S Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche CD3 Target Drug Product Offerings
Table 64. Roche CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Roche Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi CD3 Target Drug Product Offerings
Table 68. Sanofi CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Immunocore Ltd. Company Summary
Table 71. Immunocore Ltd. CD3 Target Drug Product Offerings
Table 72. Immunocore Ltd. CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Immunocore Ltd. Key News & Latest Developments
Table 74. Regeneron Pharmaceuticals Company Summary
Table 75. Regeneron Pharmaceuticals CD3 Target Drug Product Offerings
Table 76. Regeneron Pharmaceuticals CD3 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Regeneron Pharmaceuticals Key News & Latest Developments
Table 78. CD3 Target Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global CD3 Target Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global CD3 Target Drug Production by Region, 2018-2023 (K Units)
Table 81. Global CD3 Target Drug Production by Region, 2024-2029 (K Units)
Table 82. CD3 Target Drug Market Opportunities & Trends in Global Market
Table 83. CD3 Target Drug Market Drivers in Global Market
Table 84. CD3 Target Drug Market Restraints in Global Market
Table 85. CD3 Target Drug Raw Materials
Table 86. CD3 Target Drug Raw Materials Suppliers in Global Market
Table 87. Typical CD3 Target Drug Downstream
Table 88. CD3 Target Drug Downstream Clients in Global Market
Table 89. CD3 Target Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. CD3 Target Drug Segment by Type in 2022
Figure 2. CD3 Target Drug Segment by Application in 2022
Figure 3. Global CD3 Target Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CD3 Target Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CD3 Target Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. CD3 Target Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by CD3 Target Drug Revenue in 2022
Figure 9. By Type - Global CD3 Target Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global CD3 Target Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global CD3 Target Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global CD3 Target Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global CD3 Target Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global CD3 Target Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global CD3 Target Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global CD3 Target Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global CD3 Target Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global CD3 Target Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global CD3 Target Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global CD3 Target Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America CD3 Target Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America CD3 Target Drug Sales Market Share, 2018-2029
Figure 23. US CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe CD3 Target Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe CD3 Target Drug Sales Market Share, 2018-2029
Figure 28. Germany CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia CD3 Target Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia CD3 Target Drug Sales Market Share, 2018-2029
Figure 37. China CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America CD3 Target Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America CD3 Target Drug Sales Market Share, 2018-2029
Figure 44. Brazil CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa CD3 Target Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa CD3 Target Drug Sales Market Share, 2018-2029
Figure 48. Turkey CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE CD3 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global CD3 Target Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production CD3 Target Drug by Region, 2022 VS 2029
Figure 54. CD3 Target Drug Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • CD20標的薬のグローバル市場展望 2023年-2029年：CD20ターゲット、CD20+CD3ターゲット
  • CAR T細胞療法の世界市場2023年：CD19-対象、BCMA-対象
  • ピモジド抗精神病薬のグローバル市場展望 2023年-2029年：1Mg、2Mg、4Mg
  • 植物由来医薬品のグローバル市場展望 2023年-2029年：丸薬、錠剤、カプセル
  • 運動促進薬のグローバル市場展望 2023年-2029年：メトクロプラミド、ドンペリドン、シサプリド、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14268 )"CD3標的薬物のグローバル市場展望 2023年-2029年：CD20+CD3ターゲット、CD3ターゲット、BCMA+CD3ターゲット、CD3+gp100ターゲット、CD3+GPRC5Dターゲット" (英文：CD3 Target Drug Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。